Combination will generate 'new possibilities' in supply chain solutions, say firms
Noting that the two companies have been working together for over 10 years to provide 3PL services to healthcare products companies, the two will now offer combined global transportation, warehousing and distribution services. FedEx brings, among other things, the No. 1 air cargo airline; Cardinal brings its 39 distribution centers, and expertise in managing healthcare products shipping. The combination will provide a single point of contact, and visibility across the FedEx and Cardinal networks.The companies say that among the improved service capabilities are direct-to-patient deliveries and deliveries to specific departments within hospitals.
As explained by Sanjeeth Pai, VP for Cardinal Pharmaceutical Stategic Sourcing, and Jenn Lewis, director of marketing for Cardinal Integrated Logistics Services, the company has had FedEx as a primary carrier for its OptiFreight business for 10 years (OptiFreight is focused on medical products deliveries). Now the relationship is being extended to the pharma 3PL business. These medical and pharma 3PL services are “firewalled” from the pharma and med distribution businesses of Cardinal; in effect, they are acting as an independent 3PL. However, the two DCs operated by Cardinal Specialty Pharmaceutical Solutions (in LaVergne, TN and Reno, NV), the general DC of FedEx in Memphis, and—when business needs warrant—DCs in Cardinal’s wholesaling business are all resources that can be brought to bear.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.